National Institute on Drug Abuse
Director's Report to the National Advisory Council on Drug Abuse
September, 1996
Meetings/Conferences
NIDA co-sponsored the Conference On Drug Abuse (CODA) with the
American Psychological Association, Science Directorate, as a satellite
conference to APA's 104th Convention in Toronto, Ontario, August 9-13, 1996.
The goal of CODA was to highlight the best in drug abuse and addiction research.
The conference included approximately 100 coordinated drug abuse research
activities including a special address by Dr. Alan Leshner, 16 keynote speeches,
5 continuing education training workshops, a reception, several grant application
training workshops, program initiative workshops and other special programs
as well as drug abuse symposia, paper, and poster sessions. The CODA Steering
Committee worked with a contractor to develop a colorful site on the NIDA
homepage. The site served as a useful tool for sharing information about
the August Conference. A link was also created to the APA home page.
NIDA's Office of Science Policy and Communications organized a "Town
Meeting"
co-sponsored by NIDA and the Ohio Department of Alcohol and Drug Addiction
Services, "Strengthening Communities Through Prevention,"
in Columbus, on May 9, 1996. The meeting brought together local and state
policy makers and professionals in the alcohol and drug abuse field to learn
about effective, community-based prevention strategies/models from leading
researchers.
On June 27-28, 1996 a CPDD satellite meeting on the "Use, Abuse,
and Sequelae of Methamphetamine Abuse with Implications for Prevention,
Treatment and Research" was held in San Juan, Puerto Rico. The
meeting was sponsored by SAMHSA in collaboration with NIDA. Dr. Jerry Frankenheim,
DBR and Dr. Dorynne Czechowicz, DCSR, presented information on NIDA's current
portfolio of methamphetamine research. Dr. Frank Vocci, Acting Director,
MDD, presented on medication development for psychostimulant abuse. NIDA
funded grantees presented on the epidemiology of methamphetamine abuse and
implications for prevention approaches; basic pharmacology and mechanisms
of action; medical complications; treatment and prevention research. The
NIDA representatives also participated in workgroup discussions of Basic
Pharmacology and Mechanisms of Action; Medical complications and Management;
and Treatment and Prevention. A report of the meeting, including the workgroup
discussions, is being prepared by Dr. Scott Lucas, the methamphetamine meeting
Chair.
A Hispanic Research Conference sponsored by NIDA was held as a satellite
meeting at CPDD on June 21-22, 1996 in Puerto Rico. Presentations included
sessions on patterns of drug abuse for Mexican-Americans and Puerto Ricans,
recruiting and retaining Hispanic subjects in drug abuse and AIDS research,
drug treatment careers among Hispanic populations, and social support and
drug use.
NIDA's Hispanic Work Group met on June 20, 1996 in Puerto Rico. A
highlight of the meeting was a panel presentation by young researchers who
discussed the obstacles and supports encountered in developing research
careers.
NIDA's Special Populations Office and the State University of New York at
Old Westbury sponsored a Special Populations Research Development Workshop
on "Morphine and Nitric Oxide" in Melville, L.I., NY on
June 5-7, 1996. Approximately 20 faculty and trainee attendees took part
in lectures and hands-on demonstrations of various imaging processing and
analyses of nitric oxide, including computer-assisted microscopy, and learned
about applications of these techniques in biomedical research.
NIDA's Special Populations Office sponsored a panel at the National Medical
Association's Convention in Chicago on July 30, 1996. The panel focused
on drug abuse in physicians.
NIDA's African American Researchers and Scholars Meeting was held
in New Orleans on July 28, 1996. Participants discussed improving drug abuse
research in African American communities, and on increasing involvement
by African American and other ethnic minority researchers in research supported
by NIDA and NIH.
A NIDA- and ORMH-supported conference on "Creating Partnerships
and Collaborations between Minority Populations Researchers, Community-Based
Drug Abuse Treatment and Research Programs" was held July 29-August
1, 1996 in New Orleans, LA. About 200 participants attended plenaries, workshops,
and poster sessions on community-based research, collaboration between researchers,
research institutions and community-based organizations, and technical assistance
sessions on developing competitive research proposals.
NIDA's Special Populations Office cosponsored the American Psychological
Association's "Diversity Project 2000 Summer Institute 1996"
in Toronto on August 7-10, 1996. Twenty-five ethnic minority students from
U.S. community colleges and their faculty sponsors attended this mentoring
and leadership building program, which oriented students to career and higher
education opportunities in psychology. As part of the Institute, NIDA presented
a one-day program which focused on NIDA and NIH research programs, careers
in psychology, and preparation for careers in drug abuse research.
NIDA's Services Research Branch sponsored a health services research seminar,
"Financing and Costs of Drug Treatment," June 19 in the
Parklawn Building. The seminar included presentations by NIDA-funded investigators
Drs. Richard Frank, Constance Horgan, Dennis McCarty, and Michael French.
Dr. Cartwright of the Services Research Branch chaired the session and presented
a paper entitled "Drug Abuse Treatment Costs: Findings from a New Methodology".
On September 8-14 and in collaboration with the University of Miami, NIDA
sponsored a workshop entitled "Andean Region Drug Abuse Epidemiology
Methods and Research Development" in Miami, Florida. The workshop
was co-chaired by Mario De La Rosa, Ph.D., of the Office of Special Populations,
Moira O'Brien of DEPR, and J. Bryan Page, Ph.D., of the University of Miami.
NIDA Deputy Director Richard A. Millstein, who had met with members of the
planning committee last year in Rockville, gave the opening address to the
researchers from Colombia, Venezuela, Peru, Ecuador, Bolivia, and Chile.
Robert Heimer, Ph.D., of Yale University was invited by NIDA, under the
auspices of CRB/DEPR and the Office on AIDS, to present a lecture entitled
"New Rigs for Old: Virologic and Molecular Epidemiologic Underpinnings
of Needle/Syringe Exchange," held on the NIH campus on June 19.
Dr. Heimer described his evaluation research to determine the effects of
New Haven's Needle Exchange Program (NEP) on the spread of HIV. Using polymerase
chain reaction and EIA, he and colleagues have demonstrated that the New
Haven NEP has slowed the spread of HIV among IDUs by at least one third.
Dr. Heimer also described their current work to elaborate the unobtrusive
needle testing and syringe tracking methods used to assess NEP effects on
the spread of HIV in order to determine transmission patterns of acute and
chronic hepatitis infections.
The Behavioral Sciences Research Branch held a Question and Answer Session
on Training and Funding Opportunities in the Basic Behavioral Sciences of
Drug Abuse at the College on Problems of Drug Dependence meeting in
San Juan, Puerto Rico in June 1996.
Alan I. Leshner, Ph.D. and Dr. Timothy Condon co-chaired the first annual
NIDA Training Directors Meeting in Rockville, MD, May 1, 1996. Forty-two
of NIDA's forty-four training directors were able to attend. During the
morning session, NIDA staff briefed the Training Director's on current trends,
opportunities and policies. In the afternoon, participants broke into work
groups and focused on evaluating current training strategies and developing
creative responses to emerging trends in the field. NIDA Deputy Director
Richard Millstein and NIDA's Division Directors also attended.
NIDA Deputy Director Richard A. Millstein presented at and moderated an
all-day symposium on drug abuse research findings held June 1, 1996 in Honolulu,
Hawaii as a pre-conference satellite to the 1996 NASADAD Annual Meeting.
Attendees were nearly 50 state alcohol and drug abuse program directors
and their staff and local Hawaiian scientists and legislators.
NIDA Deputy Director Richard A. Millstein presented historical context remarks
at the 20th anniversary meeting of the National Institute on Drug Abuse
Community Epidemiology Work Group, held in New York City June 4-7, 1996.
NIDA Deputy Director Richard A. Millstein presented a keynote address on
findings from drug abuse prevention research at the Cornell University
Medical College Institute for Prevention Research's Conference on Multi-Ethnic
Drug Abuse Prevention Research Findings and Implications for Practice,
June 6 - 7, 1996, in New York City.
NIDA Deputy Director Richard A. Millstein represented NIH Director Dr. Harold
Varmus and NIDA Director Dr. Alan I. Leshner at the National Leadership
Forum on Preventing Substance Abuse and HIV held August 14-16, 1996
in Tampa, Florida. The Forum responded to the request of President Clinton
at the December 6, 1995 White House Meeting on AIDS that CDC "convene
a meeting of state and local people involved in both public health and drug
prevention to develop an action plan that integrates HIV prevention and
substance abuse prevention." Federal sponsors in addition to CDC were
SAMHSA, HRSA, the Office of National AIDS Policy, the Office of National
Drug Control Policy, and NIDA/NIH. National organizations co-sponsoring
the meeting included NASADAD, the Association of State and Territorial Health
Officials, the National Alliance of State and Territorial AIDS Directors,
Join Together, the Partnership for a Drug-Free America, the National Prevention
League, and the Community Anti Drug Coalitions of America.
Dr. Steven Gust, Acting Director of NIDA's Office on AIDS presented an "Overview
of HIV/AIDS Research at the NIDA, NIH" and presented a NIDA/OoA
poster session at the June CPDD Conference held in San Juan Puerto Rico.
Dr. Gust held a training session on NIDA research grants and research training
opportunities in the area of drug abuse-related HIV/AIDS in May at the University
of Minnesota.
Ms. J.C. Comolli of NIDA's Office on AIDS attended a July 31 meeting at
the Office of National Drug Control Policy (ONDCP) with representatives
from the National Alliance of State and Territorial AIDS Directors (NASTAD),
and staff from the Office on National AIDS Policy and the HHS Office of
Planning and Evaluation. NASTAD requested the meeting to present findings
from the States on ways to reduce the spread of infectious diseases related
to drug use and to present areas of collaboration at the state and local
level.
Dr. Lula Beatty, Director of NIDA's Special Populations Office, was a panelist
discussing federal initiatives and opportunities in violence and drug abuse
prevention at the annual convention of the Association of Black Psychologists
in Chicago on August 2, 1996.
Dr. David Johnson, DBR, BNRB, represented NIDA at a meeting entitled "Exploring
Alternatives to Abstinence for Nicotine Dependence" sponsored by
the Robert Wood Johnson Foundation in Newark, NJ on May 23, 1996.
Dr. Tom Aigner, DBR, BNRB, represented NIDA at the XVI Congress of the
International Primatological Society in Madison, WI on August 11-16,
1996.
Dr. Jaylan S.Turkkan, Chief of the Behavioral Sciences Research Branch,
Division of Basic Research, chaired the Federal Funding Poster Session
at the San Francisco annual meeting of the American Psychological Society
(June 29- July 2, 1996).
Dr. Jaylan Turkkan and Dr. Timothy Condon held a breakfast roundtable entitled
"Cents and Sensibility: How to Support Your Career in Drug Abuse
Research" at the American Psychological Society Meeting in San
Francisco in July, 1996. They discussed research training and early research
career support opportunities such as fellowships, career development awards,
and the newly initiated NIDA B/START program.
Dr. Jaylan Turkkan gave a presentation as discussant in a symposium entitled
"Laboratory Models of Drug Abuse" at the American Psychological
Association annual meeting in Toronto, Canada in August. She also chaired
a lecture session given by Dr. Robert Balster entitled "Scientific
Perspectives on Inhalant Abuse".
Dr. David Shurtleff chaired a lecture session at the American Psychological
Association given by Dr. Thomas Coates "Drug Abuse and HIV Transmission:
What's Needed to Protect the Next Generation".
Dr. Cora Lee Wetherington hosted a NIDA hospitality suite event at the American
Psychological Association annual meeting in Toronto, Canada entitled "Drug
Abuse, Women and Gender Differences: Research Opportunities at NIDA".
Dr. Lynda Erinoff co-chaired a symposium at the College on Problems of Drug
Dependence entitled "Using Molecular Biological Tools to Explore
Behavior".
Dr. Cora Lee Wetherington was a discussant in a symposium entitled "Drugs
of Abuse and Gender Differences" at the College on Problems of
Drug Dependence meeting in San Juan, Puerto Rico.
On May 13, Dr. Frank Vocci presented at a Loyola University of Chicago sponsored
symposium entitled Cocaine and the Amphetamines: Effects on Brain and
Behavior. The title of Dr. Vocci's presentation was: "Neurobiological
Advances in the Pharmacology of Cocaine: Implications for Medications Development."
On May 18, Joel Egertson, Senior Advisor to the Director, Medications Development
Division, gave a presentation entitled "Expanding Drug Abuse Treatment:
We're All In This Together" at the Maryland Addictions Directors
Council (MADC) Conference on "Coping with Change: Getting a Grip"
in Ocean City MD. Mr. Egertson discussed the work of the NIDA medications
development program, and the role of pharmacotherapy in drug abuse treatment
in an environment of managed care and cost containment in health care.
On June 5, Dr. Peter Cohen presented a seminar (organized by MDD) with Mercedis
Serabian, Ph.D., on "Regulatory and Ethical Issues in the Development
of an Anti-Cocaine Vaccine."
On June 19-22, Dr. Peter Cohen participated in the Eighth Annual Bioethics
Summer Retreat, Copper Mountain, Colorado. Discussions included: "Screening
Pregnant Women and Babies for HIV Infection: Privacy and its Limits"
and "Perinatal AIDS: Maternal/Fetal Conflict".
On June 24, Drs. James Hill and Frank Vocci co-chaired a workshop at the
College on Problems of Drug Dependence meeting in San Juan, Puerto Rico.
The purpose of the workshop was to illustrate new statistical methods used
in the evaluation of urine testing for illicit drugs as an efficacy marker
for potential pharmacotherapies. Dr. K.-Y. Liang of Johns Hopkins University
spoke of his longitudinal analysis methods and their application to the
evaluation of illicit drug use in urine data in clinical trials involving
new medications.
On June 24, Dr. Peter Bridge of MDD served as a discussant at the CPDD session
on Substance Abuse Medication Development and HIV Infection.
On June 27, Dr. Frank Vocci presented the approaches to development of a
medications for cocaine dependence to a satellite meeting on methamphetamine
abuse. The meeting was co sponsored by CSAT and CPDD.
On August 12, Dr. Frank Vocci served as a discussant at a session entitled,
"Current Trends in the Pharmacotherapy of Opiate Abuse"
at the American Psychological Association meeting in Toronto, Canada.
Dr. Joseph Frascella, Chief of the Etiology and Clinical Neurobiology Branch,
Division of Clinical and Services Research served as a moderator for the
oral research presentations at the recent meeting, "Building International
Research in Drug Abuse: Opportunities and Challenges" at the CPDD
meeting in San Juan, Puerto Rico, on June 22, 1996.
Dr. Frascella was a faculty participant in the "NIDA Special Populations
Research Training Workshop on Morphine and Nitric Oxide" held in
Melville, New York, June 5 - 7, 1996. He gave a seminar entitled "Neuroscience
Research at NIDA" as well as a seminar entitled "Critical
Aspects of the Grant Process."
Dr. Mac Horton of the Etiology and Clinical Neurobiology Branch, Division
of Clinical and Services Research, presented a workshop on "Neuropsychology
of Drug Abuse: Assessment, Residual Effects and Ecological Validity"
to the Psychology Staff and interns at Crownsville State Hospital Center,
Crownsville, Maryland, on May 17, 1996.
Dr. Horton attended the 104th American Psychological Association Annual
Convention in Toronto, Canada, August 8-13, 1996 and chaired a Symposium
on "Neurobiological and Neuropsychological Assessment of Drug Abuse",
a Poster Session on "Applied Research on Addictions," and
an Invited Address by George De Leon, Ph.D, on "Therapeutic Community:
Advances in Research and Practice."
Dr. Harold Gordon presented a paper at the 104th American Psychological
Association Annual Convention in Toronto, Canada, August 8-13, 1996
entitled, "Environmental and Biological Interactions: Etiologies
of Drug Abuse and Violence," which summarized data by NIDA grantees
and others suggesting some common biological and environmental factors underlying
both drug abuse and violent behavior. Dr. Gordon also chaired an Invited
Address by Jack Henningfield, Ph.D, of NIDA's Division of Intramural Research
on "Public Policy Foundation: Up in Smoke--Nicotine Research Travails."
On July 10, 1996 Dr. Dorynne Czechowicz, TRB, DCSR represented NIDA at an
Institute of Medicine Planning Workshop on Attention Deficit Hyperactivity
Disorder: Issues of Definition, Diagnosis, and Management which was
held at the National Academy of Sciences, Washington, D.C. Federal representatives
from NIDA, NIMH, NICHD, and the Department of Education Office of Special
Education Programs participated in discussions of Federal Interests and
Research Priorities.
Drs. Elizabeth Rahdert and Lisa Onken of the Division of Clinical and Services
Research participated in the Annual Convention of the American Psychological
Association (APA), held August 9-13, 1996, in Toronto, Canada. Dr. Rahdert
organized and participated in the continuing education (C.E.) workshop entitled
"Adolescent Drug Abuse Treatment Strategies" and the NIDA
Child and Adolescent Workgroup hospitality suite hour entitled "Research
and Clinical Applications in Child and Adolescent Drug Abuse: Dialog and
Resources." She also chaired the symposium "Assessment
Associated with Adolescent Drug Abuse Treatment" and served as
the discussant on the symposium "Recent Findings on Adolescent Drug
Abuse and Protective Factors." Dr. Onken organized and chaired
the C.E. workshop entitled "Drug Addiction Treatment: Clinical Applications
of Recent Research Advances."
Mr. Thomas Vischi and Dr. William S. Cartwright assisted in the planning
of the Secretary's national conference, "Access and Opportunity:
A National Leadership Conference on Managed Behavioral Health Care,"
May 14 and 15, 1996, Arlington, VA.
Dr. Frank Tims chaired a NIDA symposium, "Managed Care Research
and Institutional Change," in conjunction with the annual meeting
of the Association for Health Services Research in Atlanta, August 9. The
symposium presented research on the implementation and impact of financing
drug treatment services through managed care arrangements. Dr. William
Cartwright served as a discussant in that symposium.
Dr. Bennett Fletcher attended the American Psychological Association meeting
in Toronto August 9-13. He presented two papers, "A Brief History
of Treatment Outcome Research in the United States" and "Drug
Abuse Treatment and Services: Reducing Violence in the Community"
(co-authored with Dr. Peter Delany), and also served as a discussant in
a symposium presenting recent NIDA-funded research on treating special populations
in therapeutic communities.
Timothy P. Condon, Ph.D., NIDA's Associate Director for Science Policy,
and Theresa Levitin, Ph.D., Deputy Director, OEPR co-chaired a Grant
Writing Workshop for young researchers at the College on Problems of
Drug Dependence annual meeting in San Juan, Puerto Rico, April 23, 1996.
Participants saw a "mock IRG" review and received a resource guide
of information, contacts and selected articles.
Dr. Timothy Condon was invited to address the American Psychological
Society's (APS) Annual Board Meeting, June 29 1996, during APS's 8th
Annual Convention in San Francisco, California, June 29-July 2, 1996. He
discussed NIDA's research portfolio and research training efforts.
At the Conference On Drug Abuse in Toronto, August 12, 1996, Drs. Condon,
Levitin, and Turkkan hosted a grant writing workshop. Dr. Condon also co-hosted
a session entitled "Seeking NIDA Funding on the Neurobiological
Basis of Drug-Related Behavior" with Dr. Harold Gordon, DEPR. In
addition, Ms. Carolyn Mosher, OSPC hosted a workshop on "NIDA's
Innovative Science Education Program".
Dr. Condon was invited to address the Annual Meeting of the American Academy
of Child and Adolescent Psychiatry's (AACAP) standing Research Workgroup,
on August 14, 1996, in Washington, D.C. He spoke about NIDA's research portfolio,
research training, and efforts to recruit child and adolescent psychiatrists
into drug abuse and addiction research.
Dr. Cora Lee Wetherington, NIDA's Women's Health Coordinator, co-chaired
a session, "Drugs of Abuse and Gender Differences" at the
annual CPDD meeting in San Juan. She also served as the discussant for the
symposium.
Dr. Cora Lee Wetherington hosted a hospitality hour, "Drug Abuse,
Women, and Gender Differences: Research Opportunities at NIDA" at
the NIDA/APA organized Conference on Drug Abuse at the annual meeting of
the American Psychological Association in Toronto.
Drs. Zili Sloboda, William Bukoski and Rebecca Ashery represented NIDA's
Division of Epidemiology and Prevention Research at the Society for Prevention
Research meeting held in San Juan, Puerto Rico. In conjunction with
this meeting Dr. Ashery also held a small meeting with experts in the field
to examine the issue of child monitoring for family prevention intervention.
At the NIDA/American Psychological Association Science Directorate co-sponsored
Conference on Drug Abuse (Toronto, Ontario, August 9-13, 1996) Meyer Glantz,
Ph.D. of DEPR chaired several sessions of etiology researchers to explore
more formal efforts to integrate and facilitate the activities and community
of etiology researchers. Several initiatives were proposed and these will
be explored further and developed by NIDA's Resiliency and Risk/ Etiology
Workgroup during the coming year. Included is an increased presence and
involvement of etiology research in the activities and mission of the Society
for Prevention Research.
Richard H. Needle, Ph.D., M.P.H., presented highlights from the research
portfolio of the Community Research Branch, DEPR for the August 2, 1996
inaugural of the new location of the National Development and Research Institutes,
Inc. in New York City. NDRI moved from Beach Street to the Two World Trade
Center.
Richard H. Needle, Ph.D., M.P.H., appeared on a WORLDNET broadcast to Latin
America on August 8 which focused on "Illegal Narcotics and AIDS:
Ties that Bind." Dr. Needle, along with Dr. Larry Bruni, a Washington-area
physician known for his work with HIV-positive patients, engaged in an interactive,
question-and-answer discussion with overseas panelists from Peru, Ecuador,
and Barbados. The WORLDNET Dialogue program was the seventh in a series
on Narcotics Issues that have been produced by the U.S. Information Agency
Television and Film Service. Prior programs have addressed the environmental
impact of cocoa production, the economic impact of money laundering in Latin
America, drug prevention programs for youth, and drug abuse prevention and
treatment for the general population.
Dr. Richard H. Needle, Ph.D., M.P.H., gave a presentation on research priorities
in community based prevention of the risk behaviors associated with drug
abuse, HIV/AIDS, and other infectious diseases, at the Institute for
Health Care Policy at Georgetown University Medical Center in Washington,
D.C., on August 12.
Dr. Leslie Cooper, ERB/DEPR, recently served as the Co-Chair for the Healthy
People 2000 Progress Report Sub-Workgroup for Priority Area 14 (Maternal
and Infant Health) on Substance Abuse. She also served as an active
member of the Healthy People 2000 Progress Review for the Black Americans
Sub-Workgroups for both Research and Health Services.
Dr. Coryl Jones, ERB/DEPR, has participated in the steering committees for
several national efforts focused on child abuse and on domestic violence.
One of the results will be the National Conference on Child Abuse and Neglect
to be held in Washington, DC, September 16-21, 1996. Another activity is
the coordinating committee of agencies providing research support on child
abuse and on domestic violence.
Mario De La Rosa, Ph.D., formerly with CRB/DEPR and now with NIDA's Office
of Special Populations, gave two presentations at the NIDA-sponsored Hispanic
Drug Abuse and AIDS Research Conference, held in conjunction with the annual
meeting of the College on Problems of Drug Dependency in San Juan, Puerto
Rico in June. One presentation was on "The Role of Social Support
Systems in Drug Use Behavior of Hispanics," and the second was
on "The State of Drug Abuse Research among Hispanics."
Susan Coyle, Ph.D., of CRB/DEPR represented NIDA at the American Sociological
Association's 5th Annual Research Support Forum. The forum, held August
17-18 during ASA's annual meeting in New York City, included a poster session
for participants to talk one-on-one with Federal program officials about
research priorities, research grant application procedures, and specific
areas of research interest and concern.
Peter Hartsock, Ph.D., served on the Advisory Committee for the National
Council on International Health's Annual Conference in Washington, D.C.,
June 9-12. The theme of the conference was new and emerging infectious diseases
(EREIDs). In recognition of the
increasing health threat and global importance of EREIDs, Vice President
Albert Gore and DHHS Secretary Donna Shalala released a Presidential Decision
Directive at the conference that pledged additional Federal support for
new research in this area.
Mario De La Rosa, Ph.D., of NIDA's Office of Special Populations, gave a
presentation on "Developing a Conceptual Model to Understand the
Drug Use/Crime Relationship" at the American Psychological Association
annual meeting in Toronto, Canada on August 11, 1996.
Dr. Edythe D. London, DIR, presented a paper entitled, "Cocaine-Related
Cues Elicit Craving and Activate Cortical Circuits Relevant to Episodic
Memory" at the 51st annual meeting of the Society of Biological
Psychiatry, New York, NY, May 1-5, 1996.
Dr. Edythe D. London presented a lecture entitled, "Correlation
of Cue-Elicited Cocaine Craving with Metabolic Activation in Prefrontal
Cortex and Medial Temporal Lobe" at the annual meeting of the College
on Problems of Drug Dependence, San Juan, PR, June 22-27, 1996.
Dr. Monique Ernst, DIR, presented papers entitled, "Influence of
Sex and Age on Brain Glucose Metabolism in Control and ADHD Adults"
and "Low Dopamine Activity in Lesch-Nyhan Disease. An 18F-fluorodopa
PET Study" at the Annual Meeting of the Society for Nuclear Medicine,
Denver, CO, June 1996.
Dr. Alexis Thompson, DIR, presented a paper entitled, "Evidence
that Kappa-Opioid Agonists Induce Long-Term Alterations in Dopamine Uptake
and Release" at the International Narcotics Research Conference,
Long Beach, CA, July 21-26, 1996.
Dr. Alexis Thompson presented a paper entitled, "Interaction of
Kappa-Opioid Agonists with Cocaine: Characterization by Quantitative Microdialysis"
at the annual meeting of the College on Problems of Drug Dependence, San
Juan, PR, June 22-27, 1996.
Dr. Bruce Vaupel, DIR, presented a paper entitled, "Rate of Morphine
Administration Affects Subjective Responses of Experienced Heroin Users"
at the International Narcotics Research Conference, Long Beach, CA, July
21-26, 1996.
Dr. Ronald Herning, DIR, presented a paper entitled, "Electrophysiological
Findings in Substance Abuse" at the 3rd annual Psychiatric Electrophysiological
Association in Miami, FL, May 1996.
Dr. Tsung Ping Su, DIR, presented a paper entitled, "Delta Opioid
Peptide, DADLE, Attenuates METH-Induced DA Neurotoxicity in Mice"
at the 1996 International Narcotics Research Conference, Long Beach, CA,
July 21-26, 1996.
Dr. Jean Lud Cadet, DIR, presented a paper entitled, "Methamphetamine
Induces Apoptosis in Neural Cells" at the annual meeting of the
College on Problems of Drug Dependence, San Juan, PR, June 22-27, 1996.
Dr. Karen Bolla, DIR, presented a paper entitled, "Differential
Effects of Withdrawal on Neurocognitive Functioning in Cocaine and Cocaine
and Alcohol Abusers" at the annual meeting of the College on Problems
of Drug Dependence, San Juan, PR, June 22-27, 1996.
Dr. Ronald Herning presented a paper entitled, "Gender Differences
in Cocaine Dependence: Preliminary Neuropsychiatric Findings" at
the annual meeting of the College on Problems of Drug Dependence, San Juan,
PR, June 22-27, 1996.
Dr. Hema Mann, DIR, presented a paper entitled, "Multidrug Resistant
(mdrla) Knockout Mice are Differentially Affected by Methamphetamine (METH)
in Methylenedioxy-Methamphetamine (MDMA)", at the annual meeting
of the College on Problems of Drug Dependence, San Juan, PR, June 22-27,
1996.
David A. Gorelick, M.D., Ph.D., Chief, Treatment Branch, DIR, gave grand
rounds at the Neurology Service, West Los Angeles VA Medical Center, on
Aug. 16, 1996. His topic was "Neurologic Consequences of Cocaine
Use."
Jonathan L. Katz, DIR, was invited to present a paper entitled "Dopamine
Uptake Inhibitors, Agonist Efficacy and Cocaine Abuse Treatments"
as part of a symposium: Agonist Efficacy, Drug Dependence, and Medications
Development at the Annual meeting of the College on Problems of Drug Dependence.
Sari Izenwasser, DIR, was invited to give a series of lectures to graduate
students in the Department of Pharmacology at George Washington University
School of Medicine.
Sari Izenwasser was selected to present a paper entitled "Regulation
of Dopamine D2 Receptor Function by k-opioid Agonists: Biochemical and Neurochemical
Studies" as part of a symposium: Opioid-Dopamine Interactions at
the International Narcotics Research Conference.
For additional information about NIDA send e-mail to Information@nida.nih.gov
[NIDA Home Page][Office
of the Director][Report Index][Previous
Report Section] [Next Report Section]
|
|
